Catalyst Wire Dossier Catalyst Wire Dossier

Tacrolimus Eye Drops 0.03%

Tacrolimus
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tacrolimus Eye Drops 0.03%, covering 2013-05-10 to 2013-05-10. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Dry Eye Using 0.03% Tacrolimus Eye Drops [Phase 4]

See pricing